Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mepitel Film® Prophylaxis For Breast Cancer Patients Receiving Breast Radiotherapy At High Risk For Moist Desquamation: A Phase II Study

NCT04149522 is registered in ClinicalTrials.gov with Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) as lead sponsor.

NCT NCT04149522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mepitel Film® Prophylaxis For Breast Cancer Patients Receiving Breast Radiotherapy At High Risk For Moist Desquamation: A Phase II Study
Lead sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase
Phase 2
Overall status
Terminated
Start date
January 15, 2020
Completion date
November 6, 2023
Enrollment
40 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, radiation burn, radiation dermatitis, radiotherapy side effect, radiotherapy; adverse effect, dermatitis or eczema, radiotherapy; complications